Projects funded by the NCN
Assessment of the hepatoprotective effect of AP39, a new H2S donor, in a model of autoimmune hepatitis in mice.
2019/35/N/NZ7/04330
Keywords:
hydrogen sulfide acute hepatitis autoimmune hepatitis
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ7_12: Prevention of human diseases
- NZ4_4: Pathophysiology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Collegium Medicum
woj. małopolskie
Principal investigator (from the host institution):
Katarzyna Przejczowska-Pomierny
Number of co-investigators in the project: 3
Call: PRELUDIUM 18 - announced on 2019-09-16
Amount awarded: 209 760 PLN
Project start date (Y-m-d): 2020-07-20
Project end date (Y-m-d): 2023-07-19
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.